Immune phenotypes that predict COVID-19 severity.

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• Severe COVID-19 profoundly alters the immune system, but pre-existing immune factors predisposing individuals to severe disease are not well understood.
• Genome-wide association studies (GWAS) suggest links between severe COVID-19 and chemokine receptors and type I interferon pathways.

Approach:

• Utilized high-dimensional flow cytometry to analyze peripheral immune cells from individuals recovered from varying COVID-19 severities (mild, moderate, severe, critical).
• Focused on immune signatures that returned to a steady-state post-infection to identify lasting differences.
• Examined frequencies and chemokine receptor expression on T cells, MAIT cells, dendritic cells (DCs), and myeloid cells.

Key Points:

• Individuals with severe COVID-19 exhibited reduced frequencies of T cell, MAIT cell, and dendritic cell subsets post-recovery.
• Altered chemokine receptor expression, specifically reduced CCR1 and CCR2 on monocytes, was observed in severe COVID-19 survivors.
• Plasmacytoid DCs producing type I interferon were less frequent, and IFNAR2 expression was altered on myeloid cells in severe COVID-19 patients.

Conclusions:

• Identified specific immune cell subset reductions and altered chemokine receptor expression as potential immune signatures associated with severe COVID-19.
• Findings suggest dysregulation in T cells, MAIT cells, dendritic cells, and type I interferon pathways may contribute to severe COVID-19 pathogenesis.
• This research provides insights into immune mechanisms underlying severe COVID-19, potentially informing future therapeutic strategies.